Clinical Trials for CMV Infection

Study Evaluating the Efficacy and Safety of Artesunate

NCT ID: NCT06853184

This clinical trial is studying a medication called artesunate to see how effective and safe it is for treating a viral infection known as cytomegalovirus (CMV) in patients who have received solid ...

Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection

NCT ID: NCT06341686

This clinical trial is studying the use of a medication called Letermovir to help prevent cytomegalovirus (CMV) infection in people who have received a kidney transplant. CMV is a common virus that...

Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil

NCT ID: NCT06263218

Immune Reconstitution to CMV After HSCT: Impact of Clinical Factors and Therapy Strategies

NCT ID: NCT05656599

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

NCT ID: NCT06075927

This clinical trial is investigating a new treatment option for patients who have persistent infections from two viruses, Cytomegalovirus (CMV) and Epstein-Barr virus (EBV), after receiving a stem ...

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

NCT ID: NCT04832607

This clinical trial is looking at a new treatment for patients who have serious viral infections, specifically CMV, EBV, or AdV, after undergoing a stem cell transplant. The trial aims to see if tr...

Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS

NCT ID: NCT06021210

This clinical trial is studying a medication called Letermovir, which is being tested to help prevent Cytomegalovirus (CMV) infection in patients who are about to receive a hematopoietic stem cell ...